Moreover, STAT3 ASO application inhibited angiogenesis, reduced tumor metastasis, and extended the survival of hepatocellular carcinoma-bearing mice compared with the control groups [165]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.